Bill & Melinda Gates Foundation logo

Bill & Melinda Gates Foundation

North America, New York, United States, New York

Description

The Bill & Melinda Gates Foundation stands as one of the world's preeminent philanthropic organizations, established by Bill and Melinda Gates with a profound commitment to reducing inequity and improving lives globally. Unlike traditional venture capital firms, the Foundation operates primarily as a grant-making entity, channeling its vast resources towards addressing critical challenges in global health, poverty, and education. Its strategic approach is rooted in fostering innovation and delivering measurable impact, rather than seeking financial returns on its "investments."

With an endowment that has exceeded $50 billion, the Foundation possesses unparalleled financial capacity to fund ambitious initiatives worldwide. Since its inception, it has disbursed over $70 billion in grants, making it a monumental force in global development and humanitarian efforts. These funds are primarily directed towards non-profit organizations, research institutions, and, occasionally, for-profit entities whose work directly aligns with the Foundation's charitable objectives. Funding mechanisms include direct grants, as well as Program-Related Investments (PRIs), which are financial tools designed to achieve specific programmatic goals with a social return focus.

The Foundation's funding strategy is highly data-driven and outcomes-oriented, focusing on scalable solutions to complex global problems. It supports a diverse portfolio of initiatives, ranging from the development and distribution of vaccines to eradicate diseases like polio and malaria, to advancing agricultural productivity in developing nations, and improving educational outcomes. Their "investments" are characterized by a long-term perspective, aiming to create sustainable systemic change rather than short-term fixes.

While the Foundation does not issue "cheques" in the conventional venture capital sense, its funding amounts vary significantly based on the scope and nature of the project. Individual grants can range from approximately $50,000 for focused research projects or smaller-scale community initiatives, extending up to hundreds of millions of dollars for large-scale global health programs or multi-year commitments to major international organizations. This broad range reflects their commitment to supporting both foundational research and widespread implementation efforts across their core focus areas.

Investor Profile

Bill & Melinda Gates Foundation has backed more than 343 startups, with 43 new investments in the last 12 months alone. The firm has led 250 rounds, about 73% of its total and boasts 66 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Grant, Series A, Series B rounds (top funding stages).
  • Majority of deals are located in United States, United Kingdom, Canada.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
  • Led 40 rounds in the past year.
  • Typical check size: $50K – $100M.

Stage Focus

  • Grant (77%)
  • Series A (6%)
  • Series B (4%)
  • Series Unknown (4%)
  • Series C (3%)
  • Seed (3%)
  • Series E (1%)
  • Series D (1%)
  • Debt Financing (1%)
  • Post Ipo Equity (1%)

Country Focus

  • United States (54%)
  • United Kingdom (9%)
  • Canada (4%)
  • India (4%)
  • Germany (4%)
  • Kenya (3%)
  • The Netherlands (3%)
  • Switzerland (2%)
  • China (1%)
  • Nigeria (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Therapeutics
  • Biopharma
  • Education
  • Medical Device
  • Life Science
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Bill & Melinda Gates Foundation frequently co-invest with?

Omega Funds
Europe, Geneve, Switzerland, Geneva
Co-Investments: 3
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 5
Nomura
Asia, Tokyo, Japan, Tokyo
Co-Investments: 4
WuXi AppTec
Asia, Shanghai, China, Shanghai
Co-Investments: 3
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 7
Lux Capital
North America, New York, United States, New York
Co-Investments: 4
Oikocredit International
Europe, Utrecht, The Netherlands, Amersfoort
Co-Investments: 4
Omidyar Network
North America, California, United States, Redwood City
Co-Investments: 4
Flagship Pioneering
North America, Massachusetts, United States, Cambridge
Co-Investments: 4
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 7

Which angels does Bill & Melinda Gates Foundation often collaborate with?

LW
North America, Washington, United States, Seattle
Shared Deals: 1
Pratul Shroff
Asia, Gujarat, India, Ahmedabad
Shared Deals: 2
JR
North America, California, United States, San Francisco
Shared Deals: 2
TG
Asia, United Arab Emirates
Shared Deals: 1
VB
Europe, England, United Kingdom, London
Shared Deals: 1
EB
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by Bill & Melinda Gates Foundation?

Beech Biotech

Lausanne, Vaud, Switzerland

Beech Biotech is utilizing cutting-edge biology to develop innovative therapies for preeclampsia and other pregnancy-related issues.

Biotechnology
GrantJun 27, 2025
Amount Raised: $1,900,000
The Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, United States

The Children's Hospital of Philadelphia offers hospital devoted exclusively to caring for children.

Child CareHealth CareHospitalMedicalNon Profit
GrantJun 18, 2025
Amount Raised: $1,000,000
Precisio Biotix Therapeutics

Dover, Delaware, United States

Precisio Biotix Therapeutics is a US-based industry leader in precision antibacterial biological solutions.

Biotechnology
GrantJun 16, 2025
AMPP

Houston, Texas, United States

AMPP provides workforce education, credentialing, company accreditation, technological innovation and infrastructure protection services.

IndustrialProfessional ServicesTraining
GrantJun 9, 2025
Evaxion Biotech

Copenhagen, Hovedstaden, Denmark

Evaxion Biotech is devoted to the discovery and development of vaccines against cancer and infectious diseases.

Biotechnology
GrantJun 3, 2025
Amount Raised: $81,851
Axmed

Basel, Basel-Stadt, Switzerland

Axmed is a medical marketplace that offers access to medicines for healthcare providers through business and technology solutions.

Health CareMarketplaceMedicalTherapeutics
GrantMay 21, 2025
Amount Raised: $5,000,000
Evotec

Hamburg, Hamburg, Germany

Evotec is a pharmaceutical and life science company that provides drug discovery and gene therapy solutions.

BiotechnologyHealth CarePharmaceuticalTherapeutics
GrantMay 7, 2025
Amount Raised: $2,500,000
Gene Weaver

Cambridge, Cambridgeshire, United Kingdom

Gene Weaver is a naturally derived programmable tool for controlled cutting and precision insertion of large genetic payloads.

BiotechnologyGenetics
GrantMay 7, 2025
Amount Raised: $515,214
Likarda

Cambridge, Massachusetts, United States

Likarda is a biotech developing cell therapies and enabling technologies to transform the way cell therapies are delivered and function.

BiotechnologyCommercialIndustrialTherapeutics
GrantMar 12, 2025
Synvect

San Diego, California, United States

Synvect is a biotech platform that creates safe and effective ways to eliminate disease-carrying mosquitoes by stopping their breeding.

BiotechnologyLife ScienceMedical
SeedMar 11, 2025
Amount Raised: $3,000,000